PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $275,000 | -67.7% | 87,446 | -66.7% | 0.03% | -75.2% |
| Q4 2019 | $852,000 | +419.5% | 262,508 | +245.3% | 0.12% | +254.5% |
| Q3 2019 | $164,000 | -37.2% | 76,020 | -8.5% | 0.03% | +6.5% |
| Q2 2019 | $261,000 | -66.0% | 83,060 | -59.8% | 0.03% | -72.3% |
| Q1 2019 | $768,000 | +631.4% | 206,473 | +358.1% | 0.11% | +2140.0% |
| Q2 2018 | $105,000 | – | 45,069 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |